Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan versus enalapril on cardiovascular biomarkers in non-ST-elevation acute coronary syndrome
2005-002161-36Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of irbesartan in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by Sanofi. Primary endpoint: Primary efficacy outcome. Started Aug 2005; status: completed.
02
Drugs
irbesartan
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on 2005-002161-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002161-36.